These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 11303298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
    Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL.
    Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V, Mindikoglu AL, Nudo CG, Schiff ER, Tzakis A, Regev A.
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [Abstract] [Full Text] [Related]

  • 5. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
    Malik SM, Devera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J.
    Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
    Jacob DA, Neumann UP, Bahra M, Klupp J, Puhl G, Neuhaus R, Langrehr JM.
    Clin Transplant; 2006 Dec; 20(2):211-20. PubMed ID: 16640529
    [Abstract] [Full Text] [Related]

  • 8. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy.
    Sutedja DS, Gow PJ, Hubscher SG, Elias E.
    Transplant Proc; 2004 Oct; 36(8):2334-7. PubMed ID: 15561241
    [Abstract] [Full Text] [Related]

  • 9. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 10. Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma.
    Malik SM, Gupte PA, de Vera ME, Ahmad J.
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):800-6. PubMed ID: 19281869
    [Abstract] [Full Text] [Related]

  • 11. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
    Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP.
    Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228
    [Abstract] [Full Text] [Related]

  • 12. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M, Neuberger JM, Gunson BK, Hübscher SG.
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [Abstract] [Full Text] [Related]

  • 13. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, Levy MF, Gonwa TA, Klintmalm GB.
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
    Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, Hall P, Khan M, George J.
    Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
    [Abstract] [Full Text] [Related]

  • 15. De novo nonalcoholic fatty liver disease after liver transplantation.
    Seo S, Maganti K, Khehra M, Ramsamooj R, Tsodikov A, Bowlus C, McVicar J, Zern M, Torok N.
    Liver Transpl; 2007 Jun; 13(6):844-7. PubMed ID: 17029282
    [Abstract] [Full Text] [Related]

  • 16. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 17. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA, Kunde SS, Lazenby AJ, Clements RH.
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [Abstract] [Full Text] [Related]

  • 18. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL, Regev A, Casanova-Romero PY, Bejarano PA, Martinez EJ, Tzakis AG, Schiff ER.
    Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
    [Abstract] [Full Text] [Related]

  • 19. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC, Rohrer RM, Kaplan MM.
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [Abstract] [Full Text] [Related]

  • 20. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis.
    Heneghan MA, Zolfino T, Muiesan P, Portmann BC, Rela M, Heaton ND, O'grady JG.
    Liver Transpl; 2003 Sep; 9(9):921-8. PubMed ID: 12942453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.